BioSpace News Archive

The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology: In practice by digital therapeutics company Propeller Health, in partnership with the University of Colorado School of Medicine and Children’s Hospital Colorado.

Grace Therapeutics, a clinical stage biopharmaceutical company focused on rare and orphan diseases, announced that it is scheduled to speak at the Cowen Healthcare Conference in Boston.

Infuse Your Life Health Products suggests that you try its Soul Cardiovascular Sparkling Water the next time you are thirsty instead some sugary beverage.

West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share.

Therapeutic potential of Morphic pipeline expanded by inclusion of both integrin inhibitor and activator research

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the addition of three industry veterans to the Company’s management team

Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

Investment will help Vancouver-based cleantech firm commercialize technologies that promise to revolutionize agriculture

Diagnostic Solutions Laboratory continues its innovative vision to transform and improve personalized medicine by introducing its first DNA SNP test, GenomicInsight™ Genomic Health Profile powered by Opus23 Explorer™

Anixa Biosciences, Inc. announced it has extended its collaboration with The Wistar Institute and Dmitry I. Gabrilovich, M.D., Ph.D. Gabrilovich is a pioneer in the field of myeloid-derived suppressor cell (MDSC) biology and its roles in cancer progression and therapy response.